Velpatasvir Sofosbuvir


Product Details:

Minimum Order Quantity 3 Bottle
Dosage Form Tablet
Dose/Strength 400 mg + 100 mg
Packaging Type Bottle
Composition Sofosbuvir 400 mg + velpatasvir 100 mg
Brand Velasof
Packaging Size 28 Tablets

Velpatasvir is an NS5A inhibitor which is used together with sofosbuvir in the treatment of hepatitis C infection of all six major genotypes.

It provides a much-needed interferon-free option for patients with genotype 3 infection that is more economical than sofosbuvir plus daclatasvir, and in patients who have compensated cirrhosis with genotype 3, this single-pill option provides an important ribavirin-free combination that will prove a welcome alternative to what has been available to date.

Notably, unlike ledipasvir-sofosbuvir, an abbreviated duration of 8 weeks has not been studied with sofosbuvir-velpatasvir for any of the genotypes, except in conjunction with a third agent (GS-9857, an investigational pangenotypic HCV protease inhibitor).